MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021)

M. Zribi, N. Zoghlami, S. Ben Maryem, M. Bennour, H. Aounallah-Skhiri (Tunis, Tunisia)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: Our study aimed to describe mortality related to Parkinson’s disease (PD) and movement disorders in Tunisia during 2020-2021.

Background: Parkinson’s disease and related movement disorders represent significant global public health challenges. Comprehensive mortality data for these conditions have been limited in Tunisia. This study examined mortality patterns using national death certificate data from 2020-2021, considering potential impacts of the COVID-19 pandemic on healthcare access and mortality reporting.

Method: Data from the National Information System on Causes-of-Death (ISCD) were analyzed for 2020 and 2021. The ISCD coverage rate was calculated by comparing Medical Death Certificates received by the National Institute of Health to overall deaths recorded by the National Institute of Statistics. Deaths were coded using ICD-10 (CIM10) with specific codes for PD (G20), neuroleptic malignant syndrome (G21.0), secondary parkinsonism (G21.1-G21.9), and other movement disorders (G25-G26). Data were analyzed using Stata-17 software.

Results: The total number of death certificates analyzed was 46,420 in 2020 (ISCD coverage 61.2%) and 60,902 in 2021 (ISCD coverage 71.0%). PD and related movement disorders were responsible for 96 deaths in 2020 (95 PD, 1 neuroleptic malignant syndrome) and 166 deaths in 2021 (157 PD, 6 neuroleptic malignant syndrome, 1 secondary parkinsonism, 2 unspecified parkinsonism). In both years, 57.3% (2020) and 57.8% (2021) of deaths were among males, with the highest mortality in the 80-84 age group (61 deaths in 2020, 32 deaths in 2021).

Conclusion: Despite the COVID-19 pandemic, PD remained a significant cause of mortality in Tunisia across. These findings highlight its ongoing burden and underscore the need for continued focus on effective management and care, even during global health crises. Future research should explore the impact of healthcare disruptions on disease progression and mortality.

To cite this abstract in AMA style:

M. Zribi, N. Zoghlami, S. Ben Maryem, M. Bennour, H. Aounallah-Skhiri. Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021) [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/parkinsons-disease-and-movement-disorders-mortality-in-tunisia-insights-from-the-national-information-system-on-causes-of-death-2020-2021/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-and-movement-disorders-mortality-in-tunisia-insights-from-the-national-information-system-on-causes-of-death-2020-2021/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley